Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bridging the Age Gap in breast cancer: Impact of chemotherapy on quality of life in older women with early breast cancer.
Battisti NML, Reed MWR, Herbert E, Morgan JL, Collins KA, Ward SE, Holmes GR, Bradburn M, Walters SJ, Burton M, Lifford K, Edwards A, Robinson TG, Martin C, Chater T, Pemberton KJ, Shrestha A, Brennan A, Cheung KL, Todd A, Audisio RA, Wright J, Simcock R, Green T, Revell D, Gath J, Horgan K, Holcombe C, Winter MC, Naik J, Parmeshwar R, Gosney MA, Hatton MQ, Thompson AM, Wyld L, Ring A; Age Gap TMG. Battisti NML, et al. Eur J Cancer. 2021 Feb;144:269-280. doi: 10.1016/j.ejca.2020.11.022. Epub 2020 Dec 26. Eur J Cancer. 2021. PMID: 33373871 Free PMC article.
Cancer care physicians' attitudes toward do not resuscitate orders during the COVID-19 pandemic.
Kaur A, Streck B, Pergolotti M, Battisti NML, Krok-Schoen JL, Cabrera Chien L, Canin B, Ali I, Malone MV, MacKenzie A, Shahrokni A, Plotkin E, Boehmer LB, BrintzenhofeSzoc K. Kaur A, et al. Among authors: battisti nml. J Geriatr Oncol. 2024 May;15(4):101717. doi: 10.1016/j.jgo.2024.101717. Epub 2024 Feb 10. J Geriatr Oncol. 2024. PMID: 38342736 No abstract available.
Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper.
Battisti NML, De Glas N, Sedrak MS, Loh KP, Liposits G, Soto-Perez-de-Celis E, Krok-Schoen JL, Menjak IB, Ring A. Battisti NML, et al. Ther Adv Med Oncol. 2018 Nov 20;10:1758835918809610. doi: 10.1177/1758835918809610. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 30479671 Free PMC article. Review.
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience.
Battisti NML, Kingston B, King J, Denton A, Waters S, Sita-Lumsden A, Rehman F, Stavraka C, Kristeleit H, Sawyer E, Houghton D, Davidson N, Howell S, Choy J, Harper P, Roylance R, Fharat R, Mohammed K, Ring A, Johnston S. Battisti NML, et al. Breast Cancer Res Treat. 2019 Apr;174(3):731-740. doi: 10.1007/s10549-019-05134-x. Epub 2019 Jan 17. Breast Cancer Res Treat. 2019. PMID: 30656459
Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experience.
Battisti NML, True V, Chaabouni N, Chopra N, Lee K, Shepherd S, Shapira-Rotenberg T, Joshi R, McGrath S, Okines A, Parton M, Turner N, Mohammed K, Allen M, Johnston S, Ring A. Battisti NML, et al. Breast Cancer Res Treat. 2020 Jan;179(1):101-111. doi: 10.1007/s10549-019-05444-0. Epub 2019 Sep 18. Breast Cancer Res Treat. 2020. PMID: 31535318
CDK4/6 inhibition in HER2-positive breast cancer.
Battisti NML, Ring A. Battisti NML, et al. Lancet Oncol. 2020 Jun;21(6):734-735. doi: 10.1016/S1470-2045(20)30164-9. Epub 2020 Apr 27. Lancet Oncol. 2020. PMID: 32353343 No abstract available.
82 results